PWP model | PNP model | Purely public model | ||||
---|---|---|---|---|---|---|

Site 1 | Site 2 | Site 3 | Site 4 | Site 5 | Site6 | |

Alternative estimates of provider costs (staff time)
| ||||||

• % divergence from base-case provider cost estimate | -15% | -13% | -8% | -8% | -24% | -28% |

• % divergence from base-case provider cost-effectiveness estimate | -15% | -13% | -8% | -8% | -24% | -28% |

Lower limit patient cost
| ||||||

• % divergence from base-case patient cost estimate | N.A.* | N.A. | -5% | -5% | -5% | -5% |

• % divergence from base-case patient cost-effectiveness estimate | N.A. | N.A. | -4% | -3% | -1% | -1% |

Upper limit patient cost
| ||||||

• % divergence from base-case patient cost estimate | N.A. | N.A. | +5% | +5% | +5% | +5% |

• % divergence from base-case patient cost-effectiveness estimate | N.A. | N.A | +3% | +0.2% | +0.6% | +2% |

0% discount rate
| ||||||

• % divergence from base-case provider cost estimate | -3% | -3% | -3% | -3% | -3% | -3% |

• % divergence from provider cost-effectiveness estimate | -2% | -0.6% | -0.5% | -2% | -1% | -0.5% |

6% discount rate
| ||||||

• % divergence from base-case provider cost estimate | +3% | +3% | +3% | +3% | +3% | +3% |

• % divergence from provider cost-effectiveness estimate | +3% | +2% | +2% | +3% | +2% | +2% |

Effectiveness adjusted by the death rate**
| ||||||

• % divergence from base-case treatment success rate | -12% | -11% | -4% | -8% | -1% | -2% |

• % divergence from base-case societal cost-effectiveness estimate (treatment success rate) | -12% | -11% | -4% | -8% | -1.6% | -2.5% |

• % divergence from base-case cure rate | -12% | -11% | -4% | -8% | -1% | -2% |

• % divergence from base-case societal cost-effectiveness estimate (cure rate) | -12% | -11% | -4% | -8% | -1% | -2% |

Multivariate analysis (estimates of provider cost and effectiveness adjusted by the death rate are varied at the same time)
| ||||||

• % divergence from base-case provider cost estimate | -15% | -13% | -8% | -8% | -24% | -28% |

• % divergence from base-case cure rate | -12% | -11% | -4% | -8% | -1% | -2% |

• % divergence from base-case societal cost-effectiveness estimate | -25% | -23% | -11% | -15% | -25% | -30% |